While one of the functions of the α5β1–CD154 dyad is promoting tumor cell survival in the context of cancer and enhancing inflammation as well as T-cell persistence in autoimmune conditions, such an axis represents a promising therapeutic target in these diseases, with minimal collateral side effects. Here, CD40LG is linked to cancer.